Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Costa

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Oncotarget|May 19, 2018
Systematic review and meta-analysis of selected toxicities of approved <i>ALK</i> inhibitors in metastatic non-small cell lung cancerRubens Barros Costa, Ricardo L B Costa, Sarah M Talamantes, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|September 10, 2002
Morbidity and survival in advanced AIDS in Rio de Janeiro, BrazilAngela J Gadelha, Náurea Accacio, Regina L B Costa, et al.
Journal for Immunotherapy of Cancer|June 16, 2022
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinomaGanesan Ramamoorthi, Krithika Kodumudi, Colin Snyder, et al.
Advances in Radiation Oncology|January 24, 2022
Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective StudyElie Barakat, Andras Bibok, Anupam Rishi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 6, 2018
Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysisMatthew N Mills, George Q Yang, Daniel E Oliver, et al.
Frontiers in Immunology|September 3, 2019
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the ResponseKrithika N Kodumudi, Ganesan Ramamoorthi, Colin Snyder, et al.
Oncology|August 4, 2025
A real-world single-center cohort study on the tolerability of trastuzumab deruxtecan for HER2+ metastatic breast cancerAmeer Basta, Kyle Lien, Weihong Sun, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 TrialBenedito A Carneiro, Bhavana Konda, Rubens B Costa, et al.
Lupus|March 8, 2024
Childhood adverse experiences and clinical manifestations in women with systemic lupus erythematosusElisa Esteves Rossini, Jonatas Lourival Zanoveli Cunha, Gabriela L B Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2016
A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomasM Agulnik, R L B Costa, M Milhem, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Oncotarget|May 19, 2018
Systematic review and meta-analysis of selected toxicities of approved <i>ALK</i> inhibitors in metastatic non-small cell lung cancerRubens Barros Costa, Ricardo L B Costa, Sarah M Talamantes, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|September 10, 2002
Morbidity and survival in advanced AIDS in Rio de Janeiro, BrazilAngela J Gadelha, Náurea Accacio, Regina L B Costa, et al.
Journal for Immunotherapy of Cancer|June 16, 2022
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinomaGanesan Ramamoorthi, Krithika Kodumudi, Colin Snyder, et al.
Advances in Radiation Oncology|January 24, 2022
Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective StudyElie Barakat, Andras Bibok, Anupam Rishi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 6, 2018
Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysisMatthew N Mills, George Q Yang, Daniel E Oliver, et al.
Frontiers in Immunology|September 3, 2019
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the ResponseKrithika N Kodumudi, Ganesan Ramamoorthi, Colin Snyder, et al.
Oncology|August 4, 2025
A real-world single-center cohort study on the tolerability of trastuzumab deruxtecan for HER2+ metastatic breast cancerAmeer Basta, Kyle Lien, Weihong Sun, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 TrialBenedito A Carneiro, Bhavana Konda, Rubens B Costa, et al.
Lupus|March 8, 2024
Childhood adverse experiences and clinical manifestations in women with systemic lupus erythematosusElisa Esteves Rossini, Jonatas Lourival Zanoveli Cunha, Gabriela L B Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2016
A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomasM Agulnik, R L B Costa, M Milhem, et al.
Pageof 5